Flexotron Cross 60mg/3ml, syringe

The medical device is indicated for the treatment of joint pain in osteoarthritis (OA).

Active ingredient

Composition

How to take, the dosage

Synopsis

Flexotron® Cross is the first bionic cross-linked hyaluronic acid preparation for single injection on the Russian market. It is cross-linked using the patented CHAP technology. Stays in the joint 20 times longer than linear hyaluronic acid. Has a perfect combination of elastic and viscous properties. Easy to inject and easily tolerated by patients.

Contraindications

Do not use the implant to treat patients who are hypersensitive to hyaluronate-based products.

Intra-articular injections are contraindicated if there are past or current infections or skin conditions in the vicinity of the injection site.

Side effects

Similarities